Zuellig Pharma: Advancing Healthcare and Sustainability Across Asia
Zuellig Pharma is a leading healthcare services group in Asia, recognized for its long-standing presence and commitment to making healthcare more accessible. Since its establishment in 2008 in Singapore, Zuellig Pharma has operated across the region for nearly a century. With a business valued at US$13 billion, the company offers world-class distribution, digital, and commercial solutions that address Asia’s growing healthcare needs.
Today, Zuellig Pharma operates in 13 markets, employs over 12,000 professionals, and serves more than 350,000 medical facilities. It partners with over 1,000 clients, including the world’s top pharmaceutical companies, reinforcing its reputation among Asia’s trusted business leaders in healthcare.
Sustainability as a Core Value
Zuellig Pharma’s mission of making healthcare more accessible is deeply aligned with its sustainability journey. Since formalizing its agenda three years ago, the company has developed a robust sustainability framework built around four core pillars: improving health outcomes, nurturing talent, respecting the environment, and setting the highest standards of integrity.
This sustainability strategy, recognized in the sustainability awards space, integrates ESG principles and adheres to global standards. Zuellig Pharma is a committed signatory of the Ten Principles of the UN Global Compact and publishes annual GRI-aligned sustainability reports, reinforcing transparency and accountability.
Commitment to Stakeholders and ESG Excellence
Beyond internal operations, Zuellig Pharma actively collaborates with industry and global organizations, such as Business for Social Responsibility’s Healthcare Working Group and Green Freight Asia. In 2020, its inaugural Sustainability Month engaged over 7,000 employees in eco-conscious initiatives, further highlighting its culture of responsibility.
Through events like World Quality Day, Safety Week, and its Supplier Sustainability Awards, Zuellig Pharma fosters a supply chain rooted in ESG values. These initiatives showcase the company’s leadership in driving ethical, sustainable practices throughout the healthcare ecosystem.
Recognition and Achievements in Sustainability
Zuellig Pharma’s commitment has earned prestigious accolades, including the EcoVadis Gold Medal, placing it in the top 1% of companies within its industry. This recognition solidifies its reputation as a leader in corporate sustainability and validates the impact of its ESG-driven efforts.
The publication of its first GRI-aligned sustainability report marked a significant step in tackling key material issues and promoting long-term social and environmental responsibility.
Resilience and Leadership During Global Challenges
Even amid the global pandemic, Zuellig Pharma remained steadfast in embedding sustainability into daily operations. This resilience exemplifies the company’s role as a business leader in both healthcare delivery and corporate responsibility—setting benchmarks for long-term impact across Asia.
